Skip to main content
Top
Published in: BMC Infectious Diseases 1/2024

Open Access 01-12-2024 | Hepatitis C | Research

Hepatitis C virus subtype diversity and transmission clusters characteristics among drug users in Zhuhai, South China

Authors: Hongxia Li, Huitao Huang, Wenyan Huang, Man Du, Dongling Long, Guangxian Xu, Wenhua Mei, Kaisong Huang

Published in: BMC Infectious Diseases | Issue 1/2024

Login to get access

Abstract

Background

Hepatitis C virus (HCV) infection poses a major public health challenge globally, especially among injecting drug users. China has the world’s largest burden of HCV infections. However, little is known about the characteristics of transmission networks among drug user populations. This study aims to investigate the molecular epidemiology and transmission characteristics of HCV infections among drug users in Zhuhai, a bustling port city connecting Mainland China and its Special Administrative Regions.

Methods

Participants enrolled in this study were drug users incarcerated at Zhuhai’s drug rehabilitation center in 2015. Their sociodemographic and behavioral information, including gender, promiscuity, drug use method, and so forth, was collected using a standardized questionnaire. Plasmas separated from venous blood were analyzed for HCV infection through ELISA and RT-PCR methods to detect anti-HCV antibodies and HCV RNA. The 5’UTR fragment of the HCV genome was amplified and further sequenced for subtype identifications and phylogenetic analysis. The phylogenetic tree was inferred using the Maximum Likelihood method based on the Tamura-Nei model, and the transmission cluster network was constructed using Cytoscape3.8.0 software with a threshold of 0.015. Binary logistic regression models were employed to assess the factors associated with HCV infection.

Results

The overall prevalence of HCV infection among drug users was 44.37%, with approximately 19.69% appearing to clear the HCV virus successfully. Binary logistic regression analysis revealed that those aged over 40, engaging in injecting drug use, and being native residents were at heightened risk for HCV infection among drug user cohorts. The predominant HCV subtypes circulating among those drug users were 6a (60.26%), followed by 3b (16.7%), 3a (12.8%), 1b (6.41%) and 1a (3.85%), respectively. Molecular transmission network analysis unveiled the presence of six transmission clusters, with the largest propagation cluster consisting of 41 individuals infected with HCV subtype 6a. Furthermore, distinct transmission clusters involved eight individuals infected with subtype 3b and seven with subtype 3a were also observed.

Conclusion

The genetic transmission networks revealed a complex transmission pattern among drug users in Zhuhai, emphasizing the imperative for a targeted and effective intervention strategy to mitigate HCV dissemination. These insights are pivotal for shaping future national policies on HCV screening, treatment, and prevention in port cities.
Appendix
Available only for authorised users
Literature
1.
go back to reference Paraskevis D, Stylianou DC, Hezka J, Stern Z, Oikonomopoulou M, Mamais I, Cyprus PN, Kostrikis LG. HCV phylogeography of the general population and high-risk groups in Cyprus identifies the island as a global sink for and source of infection. Sci Rep. 2019;9(1):10077.CrossRefPubMedPubMedCentral Paraskevis D, Stylianou DC, Hezka J, Stern Z, Oikonomopoulou M, Mamais I, Cyprus PN, Kostrikis LG. HCV phylogeography of the general population and high-risk groups in Cyprus identifies the island as a global sink for and source of infection. Sci Rep. 2019;9(1):10077.CrossRefPubMedPubMedCentral
2.
go back to reference Thursz M, Fontanet A. HCV transmission in industrialized countries and resource-constrained areas. Nat Reviews Gastroenterol Hepatol. 2014;11(1):28–35.CrossRef Thursz M, Fontanet A. HCV transmission in industrialized countries and resource-constrained areas. Nat Reviews Gastroenterol Hepatol. 2014;11(1):28–35.CrossRef
3.
go back to reference Sahibzada KI, Ganova-Raeva L, Dimitrova Z, Ramachandran S, Lin Y, Longmire G, Arthur L, Xia GL, Khudyakov Y, Khan I, et al. Hepatitis C virus transmission cluster among injection drug users in Pakistan. PLoS ONE. 2022;17(7):e0270910.CrossRefPubMedPubMedCentral Sahibzada KI, Ganova-Raeva L, Dimitrova Z, Ramachandran S, Lin Y, Longmire G, Arthur L, Xia GL, Khudyakov Y, Khan I, et al. Hepatitis C virus transmission cluster among injection drug users in Pakistan. PLoS ONE. 2022;17(7):e0270910.CrossRefPubMedPubMedCentral
4.
go back to reference Ayoub HH, Chemaitelly H, Omori R, Abu-Raddad LJ. Hepatitis C virus infection spontaneous clearance: has it been underestimated? Int J Infect Diseases: IJID: Official Publication Int Soc Infect Dis. 2018;75:60–6. Ayoub HH, Chemaitelly H, Omori R, Abu-Raddad LJ. Hepatitis C virus infection spontaneous clearance: has it been underestimated? Int J Infect Diseases: IJID: Official Publication Int Soc Infect Dis. 2018;75:60–6.
5.
go back to reference Floderus E, Linder LE, Sund ML. Arginine catabolism by strains of oral streptococci. APMIS: acta pathologica, microbiologica, et immunologica Scandinavica. 1990;98(11):1045–1052. Floderus E, Linder LE, Sund ML. Arginine catabolism by strains of oral streptococci. APMIS: acta pathologica, microbiologica, et immunologica Scandinavica. 1990;98(11):1045–1052.
6.
go back to reference Gao Y, Yang J, Sun F, Zhan S, Fang Z, Liu X, Zhuang H. Prevalence of anti-HCV antibody among the general population in Mainland China between 1991 and 2015: a systematic review and meta-analysis. Open Forum Infect Dis. 2019;6(3):ofz040.CrossRefPubMedPubMedCentral Gao Y, Yang J, Sun F, Zhan S, Fang Z, Liu X, Zhuang H. Prevalence of anti-HCV antibody among the general population in Mainland China between 1991 and 2015: a systematic review and meta-analysis. Open Forum Infect Dis. 2019;6(3):ofz040.CrossRefPubMedPubMedCentral
7.
go back to reference Mei X, Lu H. Prevalence, diagnosis, and treatment of hepatitis C in Mainland China. Global Health Med. 2021;3(5):270–5.CrossRef Mei X, Lu H. Prevalence, diagnosis, and treatment of hepatitis C in Mainland China. Global Health Med. 2021;3(5):270–5.CrossRef
8.
go back to reference Simmonds P. Genetic diversity and evolution of hepatitis C virus–15 years on. J Gen Virol. 2004;85(Pt 11):3173–88.CrossRefPubMed Simmonds P. Genetic diversity and evolution of hepatitis C virus–15 years on. J Gen Virol. 2004;85(Pt 11):3173–88.CrossRefPubMed
10.
go back to reference Martinez MA, Franco S. Therapy implications of hepatitis C virus genetic diversity. Viruses. 2020;13(1). Martinez MA, Franco S. Therapy implications of hepatitis C virus genetic diversity. Viruses. 2020;13(1).
11.
go back to reference Tong Y, Li Q, Li R, Xu Y, Pan Y, Niu J, Zhong J. A Novel Approach to Display Structural Proteins of Hepatitis C Virus Quasispecies in patients reveals a key role of E2 HVR1 in viral evolution. J Virol 2020, 94(17). Tong Y, Li Q, Li R, Xu Y, Pan Y, Niu J, Zhong J. A Novel Approach to Display Structural Proteins of Hepatitis C Virus Quasispecies in patients reveals a key role of E2 HVR1 in viral evolution. J Virol 2020, 94(17).
12.
go back to reference Tagnouokam-Ngoupo PA, Ngoufack MN, Kenmoe S, Lissock SF, Amougou-Atsama M, Banai R, Ngono L, Njouom R. Hepatitis C virus genotyping based on core and NS5B regions in Cameroonian patients. Virol J. 2019;16(1):101.CrossRefPubMedPubMedCentral Tagnouokam-Ngoupo PA, Ngoufack MN, Kenmoe S, Lissock SF, Amougou-Atsama M, Banai R, Ngono L, Njouom R. Hepatitis C virus genotyping based on core and NS5B regions in Cameroonian patients. Virol J. 2019;16(1):101.CrossRefPubMedPubMedCentral
13.
go back to reference Deng X, Liang Z, Cai W, Li F, Li J, Hu F, Lan Y. Transmission networks of hepatitis C virus among HIV/HCV-coinfected patients in Guangdong, China. Virol J. 2022;19(1):117.CrossRefPubMedPubMedCentral Deng X, Liang Z, Cai W, Li F, Li J, Hu F, Lan Y. Transmission networks of hepatitis C virus among HIV/HCV-coinfected patients in Guangdong, China. Virol J. 2022;19(1):117.CrossRefPubMedPubMedCentral
14.
go back to reference Ramachandran S, Thai H, Forbi JC, Galang RR, Dimitrova Z, Xia GL, Lin Y, Punkova LT, Pontones PR, Gentry J et al. A large HCV transmission network enabled a fast-growing HIV outbreak in rural Indiana, 2015. EBioMedicine. 2018;37:374–381. Ramachandran S, Thai H, Forbi JC, Galang RR, Dimitrova Z, Xia GL, Lin Y, Punkova LT, Pontones PR, Gentry J et al. A large HCV transmission network enabled a fast-growing HIV outbreak in rural Indiana, 2015. EBioMedicine. 2018;37:374–381.
15.
go back to reference Shier MK, El-Wetidy MS, Ali HH, Al-Qattan MM. Characterization of hepatitis C virus genotypes by direct sequencing of HCV 5’UTR region of isolates from Saudi Arabia. PLoS ONE. 2014;9(8):e103160.CrossRefPubMedPubMedCentral Shier MK, El-Wetidy MS, Ali HH, Al-Qattan MM. Characterization of hepatitis C virus genotypes by direct sequencing of HCV 5’UTR region of isolates from Saudi Arabia. PLoS ONE. 2014;9(8):e103160.CrossRefPubMedPubMedCentral
16.
go back to reference Ullah A, Rehman IU, Ahmad J, Odenthal M, Ahmad S, Nadeem T, Ali Q, Rizwan M, Khan MA, Hassan S, et al. Phylogenetic analysis of the 5’ untranslated region of HCV from cirrhotic patients in Khyber Pakhtunkhwa, Pakistan. Sci Rep. 2021;11(1):15023.CrossRefPubMedPubMedCentral Ullah A, Rehman IU, Ahmad J, Odenthal M, Ahmad S, Nadeem T, Ali Q, Rizwan M, Khan MA, Hassan S, et al. Phylogenetic analysis of the 5’ untranslated region of HCV from cirrhotic patients in Khyber Pakhtunkhwa, Pakistan. Sci Rep. 2021;11(1):15023.CrossRefPubMedPubMedCentral
17.
go back to reference Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG, Barnes E. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2015;61(1):77–87.CrossRefPubMed Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG, Barnes E. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2015;61(1):77–87.CrossRefPubMed
18.
go back to reference Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61(1 Suppl):S45–57.CrossRefPubMed Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61(1 Suppl):S45–57.CrossRefPubMed
19.
go back to reference Asselah T, Hassanein T, Waked I, Mansouri A, Dusheiko G, Gane E. Eliminating hepatitis C within low-income countries - the need to cure genotypes 4, 5, 6. J Hepatol. 2018;68(4):814–26.CrossRefPubMed Asselah T, Hassanein T, Waked I, Mansouri A, Dusheiko G, Gane E. Eliminating hepatitis C within low-income countries - the need to cure genotypes 4, 5, 6. J Hepatol. 2018;68(4):814–26.CrossRefPubMed
20.
go back to reference Chen Y, Yu C, Yin X, Guo X, Wu S, Hou J. Hepatitis C virus genotypes and subtypes circulating in Mainland China. Emerg Microbes Infections. 2017;6(11):e95. Chen Y, Yu C, Yin X, Guo X, Wu S, Hou J. Hepatitis C virus genotypes and subtypes circulating in Mainland China. Emerg Microbes Infections. 2017;6(11):e95.
21.
go back to reference Chen YD, Liu MY, Yu WL, Li JQ, Peng M, Dai Q, Liu X, Zhou ZQ. Hepatitis C virus infections and genotypes in China. Hepatobiliary Pancreat Dis International: HBPD INT. 2002;1(2):194–201. Chen YD, Liu MY, Yu WL, Li JQ, Peng M, Dai Q, Liu X, Zhou ZQ. Hepatitis C virus infections and genotypes in China. Hepatobiliary Pancreat Dis International: HBPD INT. 2002;1(2):194–201.
22.
go back to reference HIV-1 molecular. Transmission network among sexually transmitted populations in Liaoning Province, China: Erratum. Medicine. 2021;100(31):e26853.CrossRef HIV-1 molecular. Transmission network among sexually transmitted populations in Liaoning Province, China: Erratum. Medicine. 2021;100(31):e26853.CrossRef
23.
go back to reference Yuan D, Liu M, Li Y, Jia P, Su L, Ye L, Zhang Y, Ling P, Zhou C, Liang S, et al. Genetic transmission networks of HIV-1 CRF07_BC strain among HIV-1 infections with virologic failure of ART in a minority area of China: a population-based study. BMC Infect Dis. 2020;20(1):631.CrossRefPubMedPubMedCentral Yuan D, Liu M, Li Y, Jia P, Su L, Ye L, Zhang Y, Ling P, Zhou C, Liang S, et al. Genetic transmission networks of HIV-1 CRF07_BC strain among HIV-1 infections with virologic failure of ART in a minority area of China: a population-based study. BMC Infect Dis. 2020;20(1):631.CrossRefPubMedPubMedCentral
24.
go back to reference Hochstatter KR, Tully DC, Power KA, Koepke R, Akhtar WZ, Prieve AF, Whyte T, Bean DJ, Seal DW, Allen TM, et al. Hepatitis C virus transmission clusters in public health and correctional settings, Wisconsin, USA, 2016–2017(1). Emerg Infect Dis. 2021;27(2):480–9.CrossRefPubMedPubMedCentral Hochstatter KR, Tully DC, Power KA, Koepke R, Akhtar WZ, Prieve AF, Whyte T, Bean DJ, Seal DW, Allen TM, et al. Hepatitis C virus transmission clusters in public health and correctional settings, Wisconsin, USA, 2016–2017(1). Emerg Infect Dis. 2021;27(2):480–9.CrossRefPubMedPubMedCentral
25.
go back to reference Ye J, Sun Y, Li J, Lu X, Zheng M, Liu L, Yu F, He S, Xu C, Ren X, et al. Distribution pattern, molecular transmission networks, and phylodynamic of hepatitis C virus in China. PLoS ONE. 2023;18(12):e0296053.CrossRefPubMedPubMedCentral Ye J, Sun Y, Li J, Lu X, Zheng M, Liu L, Yu F, He S, Xu C, Ren X, et al. Distribution pattern, molecular transmission networks, and phylodynamic of hepatitis C virus in China. PLoS ONE. 2023;18(12):e0296053.CrossRefPubMedPubMedCentral
26.
go back to reference Bartlett SR, Wertheim JO, Bull RA, Matthews GV, Lamoury FM, Scheffler K, Hellard M, Maher L, Dore GJ, Lloyd AR, et al. A molecular transmission network of recent hepatitis C infection in people with and without HIV: implications for targeted treatment strategies. J Viral Hepatitis. 2017;24(5):404–11.CrossRef Bartlett SR, Wertheim JO, Bull RA, Matthews GV, Lamoury FM, Scheffler K, Hellard M, Maher L, Dore GJ, Lloyd AR, et al. A molecular transmission network of recent hepatitis C infection in people with and without HIV: implications for targeted treatment strategies. J Viral Hepatitis. 2017;24(5):404–11.CrossRef
27.
go back to reference Bao YP, Liu ZM. Systematic review of HIV and HCV infection among drug users in China. Int J STD AIDS. 2009;20(6):399–405.CrossRefPubMed Bao YP, Liu ZM. Systematic review of HIV and HCV infection among drug users in China. Int J STD AIDS. 2009;20(6):399–405.CrossRefPubMed
28.
go back to reference Micallef JM, Kaldor JM, Dore GJ. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepatitis. 2006;13(1):34–41.CrossRef Micallef JM, Kaldor JM, Dore GJ. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepatitis. 2006;13(1):34–41.CrossRef
29.
go back to reference Grebely J, Page K, Sacks-Davis R, van der Loeff MS, Rice TM, Bruneau J, Morris MD, Hajarizadeh B, Amin J, Cox AL, et al. The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology. 2014;59(1):109–20.CrossRefPubMed Grebely J, Page K, Sacks-Davis R, van der Loeff MS, Rice TM, Bruneau J, Morris MD, Hajarizadeh B, Amin J, Cox AL, et al. The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology. 2014;59(1):109–20.CrossRefPubMed
30.
go back to reference Trickey A, Fraser H, Lim AG, Peacock A, Colledge S, Walker JG, Leung J, Grebely J, Larney S, Martin NK, et al. The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study. Lancet Gastroenterol Hepatol. 2019;4(6):435–44.CrossRefPubMedPubMedCentral Trickey A, Fraser H, Lim AG, Peacock A, Colledge S, Walker JG, Leung J, Grebely J, Larney S, Martin NK, et al. The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study. Lancet Gastroenterol Hepatol. 2019;4(6):435–44.CrossRefPubMedPubMedCentral
31.
go back to reference Tang Q, Chen Z, Li H, Zhang L, Peng M, Zeng Y, Liu X, Liu Z, Hu P. Molecular epidemiology of hepatitis C virus genotypes in different geographical regions of Chinese mainland and a phylogenetic analysis. Infect Dis Poverty. 2023;12(1):66.CrossRefPubMedPubMedCentral Tang Q, Chen Z, Li H, Zhang L, Peng M, Zeng Y, Liu X, Liu Z, Hu P. Molecular epidemiology of hepatitis C virus genotypes in different geographical regions of Chinese mainland and a phylogenetic analysis. Infect Dis Poverty. 2023;12(1):66.CrossRefPubMedPubMedCentral
32.
go back to reference Jia Y, Zou X, Yue W, Liu J, Yue M, Liu Y, Liu L, Huang P, Feng Y, Xia X. The distribution of hepatitis C viral genotypes shifted among chronic hepatitis C patients in Yunnan, China, between 2008–2018. Front Cell Infect Microbiol. 2023;13:1092936.CrossRefPubMedPubMedCentral Jia Y, Zou X, Yue W, Liu J, Yue M, Liu Y, Liu L, Huang P, Feng Y, Xia X. The distribution of hepatitis C viral genotypes shifted among chronic hepatitis C patients in Yunnan, China, between 2008–2018. Front Cell Infect Microbiol. 2023;13:1092936.CrossRefPubMedPubMedCentral
33.
go back to reference Lwin AA, Shinji T, Khin M, Win N, Obika M, Okada S, Koide N. Hepatitis C virus genotype distribution in Myanmar: predominance of genotype 6 and existence of new genotype 6 subtype. Hepatol Research: Official J Japan Soc Hepatol. 2007;37(5):337–45.CrossRef Lwin AA, Shinji T, Khin M, Win N, Obika M, Okada S, Koide N. Hepatitis C virus genotype distribution in Myanmar: predominance of genotype 6 and existence of new genotype 6 subtype. Hepatol Research: Official J Japan Soc Hepatol. 2007;37(5):337–45.CrossRef
Metadata
Title
Hepatitis C virus subtype diversity and transmission clusters characteristics among drug users in Zhuhai, South China
Authors
Hongxia Li
Huitao Huang
Wenyan Huang
Man Du
Dongling Long
Guangxian Xu
Wenhua Mei
Kaisong Huang
Publication date
01-12-2024
Publisher
BioMed Central
Keyword
Hepatitis C
Published in
BMC Infectious Diseases / Issue 1/2024
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-024-09323-y

Other articles of this Issue 1/2024

BMC Infectious Diseases 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.